The stock market is down Friday, with the Dow Jones Industrial Average down 0.01%, the Nasdaq down 0.51% and the S&P 500 down 0.27%. Today’s winners include a technology company which has secured financing for a restructuring and a pharmaceutical company whose drug has received positive remarks from European regulators. Today’s losers include a retailer whose ownership remains in limbo and another pharmaceutical company who is selling stock.
These are Friday’s market winners and losers.
Biggest Winners
Shares of Alcatel-Lucent, S.A. (NYSE: ALU) is up 10.29% to $1.21 on trading volume of 9.9 million shares. The firm has secured $2.1 billion in financing for a restructuring plan. The 52-week high is $2.66.
Shares of Alexza Pharmaceuticals Inc. (NASDAQ: ALXA) are up 8.57% to $5.69 on trading volume of 1.9 million shares. European regulators have called for the approval of experimental drug Adasuve, which helps with schizophrenia and bipolar disorder. The 52-week high is $9.90.
Biggest Losers
Shares of Best Buy Co. Inc. (NYSE: BBY) are down 15.01% to $12.00 on trading volume of 19.1 million shares. The company has extended the deadline for founder Richard Schulze to make a bid for the company to Feb. 28. The 52-week low is $11.28.
Shares of Cytori Therapeutics, Inc. (NASDAQ: CYTX) are down 14.76% to $2.83 on trading volume of 2.4 million shares. The company said it will sell 7 million shares of stock at $2.85 a share. The 52-week low is $1.90.
Samuel Weigley
Follow him on Twitter: SWeigley
It’s Your Money, Your Future—Own It (sponsor)
Retirement can be daunting, but it doesn’t need to be.
Imagine having an expert in your corner to help you with your financial goals. Someone to help you determine if you’re ahead, behind, or right on track. With SmartAsset, that’s not just a dream—it’s reality. This free tool connects you with pre-screened financial advisors who work in your best interests. It’s quick, it’s easy, so take the leap today and start planning smarter!
Don’t waste another minute; get started right here and help your retirement dreams become a retirement reality.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.